Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy
December 14, 2021Medical Communications
Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …
Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director
December 13, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
CAR-T therapy trials show promise for earlier use in lymphoma
December 13, 2021Sales and Marketing
Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …
New clinical trial testing diabetes drug for reducing risk of Alzheimer’s
December 13, 2021Sales and Marketing
A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …
UK government sets new booster target
December 13, 2021Sales and Marketing
The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …
Feedback receives funding for cloud-based tuberculosis programme
December 13, 2021Sales and Marketing
Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …
CDC authorise Pfizer boosters for 16- and 17-year-olds
December 10, 2021Medical Communications
The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …
FDA approves expansion for ZYNRELEF
December 10, 2021Medical Communications
The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …
Novartis announces positive results from Phase III trial of Beovu
December 9, 2021Business Services
Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …
Pfizer says COVID-19 booster shot is promising against Omicron variant
December 9, 2021The companies said that the three doses provide a similar level of antibodies against Omicron, compared to that of two …
FDA approval for first CGP test for melanoma therapeutics
December 9, 2021Business Services
The FDA has granted Foundation Medicine approval for its companion diagnostic, FoundationOne®CDx, for two groups of current and future FDA-approved …
EUA granted to AstraZeneca’s antibody therapy for COVID-19 prevention
December 9, 2021Business Services
AstraZeneca announced that its Evusheld antibody combination for the prevention of COVID-19 in immunocompromised adults and adolescents has been granted …
Abbott receives CE mark for traumatic brain injury blood test
December 8, 2021Research and Development
Abbott has received a CE mark for its laboratory traumatic brain injury (TBI) blood test. This will be the first …
Positive Phase III trial results for plant-based COVID-19 vaccine candidate
December 8, 2021Research and Development
The biopharmaceutical company Medicago, alongside GlaxoSmithKline, have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy …
Booster vaccines may be needed for ‘years to come’, says Pfizer
December 8, 2021Research and Development
Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …
WHO reject convalescent plasma treatment for COVID-19
December 7, 2021Manufacturing and Production
WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …
Study reveals young people recover quickly from rare COVID-19 side effect
December 7, 2021Manufacturing and Production
Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …
GSK antibody treatment effective against Omicron, study suggests
December 7, 2021Manufacturing and Production
GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …
Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial
December 7, 2021Manufacturing and Production
Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …
Maintaining product authenticity: The solution to a serial problem
December 6, 2021Sales and Marketing
Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
